The global liquid biopsy market is expected to grow with a significant size, approximately US$ 15.46 billion in 2033, compared to US$ 4.29 billion in 2024, at a robust CAGR of 15.30% from 2025 to 2033. This growth is because of the increasing demand for non-invasive cancer diagnostics, advancements in biomarker discovery, and rising adoption of personalized medicine.
Read More: https://www.renub.com/liquid-biopsy-market-p.php
#liquid_biopsy_market
#liquid_biopsy_market_market_trends
#liquid_biopsy_market_market_size
#liquid_biopsy_market_market_share
Like
Comment
Share
